ALTSTATION.IO

Church & Dwight Co., Inc. (CHD) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price
$101.35
Change
+0.75%
Market Cap
$24.69B
Avg Volume
2.6M

Company Overview

Church & Dwight Co., Inc. develops and sells a wide range of household and personal care products. Their offerings include popular items like laundry detergents, cat litters, and baking soda under the renowned ARM & HAMMER brand. They also produce health-related products such as condoms and lubricants under the TROJAN brand and cleaning solutions like OXICLEAN. The company sells its products through various retail channels, including supermarkets, online platforms, and discount stores, catering to both consumers and industrial customers.

In terms of market position, Church & Dwight is a significant player in the consumer defensive sector, often regarded as a market leader. Their broad and well-recognized product portfolio gives them a competitive edge over challengers like Procter & Gamble and Unilever. However, the industry faces challenges from rising raw material costs and increasing competition in the e-commerce space, which could pressure margins and market share in the future.

Currently, Church & Dwight is maintaining a growth trajectory, driven by strong brand loyalty and ongoing product innovation. The company has recently expanded its presence in the specialty products division, which is helping diversify revenue streams. With recent strategic shifts towards e-commerce and health-oriented products, Church & Dwight is well-positioned to navigate upcoming market dynamics while capitalizing on consumer trends.

Key Financials
Market Cap
$24.69B
Revenue
$6.20B
EBITDA
$1.40B
Gross Margin
45.2%
Profit Margin
11.9%
Revenue Growth
3.9%
Total Cash
$409.00M
Total Debt
$2.21B
Free Cash Flow
$1.22B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
33.56
Forward P/E
25.16
Beta
0.47
52-Week High
$116.46
52-Week Low
$81.33
EPS
$3.02
50-Day Avg
$87.54
200-Day Avg
$91.47
Price/Book
6.04
CHD 52-Week Stock Chart
Technical Analysis
The overall trend for Church & Dwight Co., Inc. (CHD) over the past 52 weeks indicates a bearish movement, with the stock declining from a high around $115 in February to the current price of $101.35, representing a 2.6% decrease. Key resistance is seen at the $100.53 level, a threshold that the stock has struggled to maintain recently, while support is identified at approximately $90, where the stock had historically rebounded. In recent weeks, there has been a slight recovery, with momentum building toward the end of January and early February, signaling a potential reversal as it approaches resistance. The price remains relatively close to the upper end of its 52-week range, suggesting that if the stock can breach resistance, it may gain further upside momentum. However, continued pressure below $100 indicates that the bearish sentiment could persist, creating volatility around these key levels.


Recent News and Developments

Here’s a summary of the latest news and developments for Church & Dwight Co., Inc

(CHD) stock from the past week (January 31, 2026 – February 7, 2026):

Market Update

### Church & Dwight Exceeds Q4 2025 Earnings Estimates and Provides Positive 2026 Outlook
Church & Dwight announced strong fourth-quarter 2025 results, reporting earnings per share (EPS) of $0.86, surpassing analyst expectations of $0.84 by 2.38%. Revenue for the quarter reached $1.64 billion, aligning with forecasts. The positive earnings report led to a 5.48% increase in the stock’s premarket tr

Market Update

### JPMorgan Upgrades Church & Dwight to Neutral
On Monday, February 2, 2026, JPMorgan upgraded Church & Dwight Co. Inc. (CHD) from an “Underweight” to a “Neutral” rating. The investment bank also raised its price target for the stock, reflecting a more optimistic view on the company’s performance and future prospects.

Market Sentiment and Analyst Recommendations

Bull Case
CHD just beat Q4 earnings by 2.38% and guided for 3-4% organic growth in 2026 with 5-8% EPS expansion, which is solid execution from a mature consumer staples player. The dividend increase to $0.3075 quarterly signals management confidence in cash generation despite carrying $2.21B in debt. JPMorgan’s upgrade from Underweight to Neutral on February 2 suggests institutional conviction is shifting positive after a rough 2025. At 33.56x P/E, the stock looks expensive on surface, but if the company delivers on that 5-8% EPS guidance, it’s pricing in minimal upside. The stock is trading near the top of its 52-week range at $101.35, and breaking through $100.53 resistance could trigger momentum toward $110-115 levels where technical support exists from earlier in the year.
Bear Case
Revenue growth of just 3.9% is anemic for a $24.69B market cap company, and that’s not accelerating despite the dividend hike. The 33.56x P/E multiple is punchy for a low-single-digit growth business, especially when the broader market offers better growth at comparable multiples. That director selling 43% of her stake on February 5 at $101 is a yellow flag, even if isolated. CHD carries $2.21B in debt against only $409M in cash, leaving limited financial flexibility if consumer spending weakens or competition intensifies in personal care and household products. The 52-week chart shows the stock down from $115 to $101, and the technical breakdown below $100.53 resistance could accelerate selling toward $90 support if earnings disappoint or guidance gets cut.
What to Watch
Monitor Q1 2026 earnings in late April for evidence that the 3-4% organic growth guidance is real or just wishful thinking. Track whether the stock can hold above $100.53 and push toward $110 as a sign of sustained momentum, or if it rolls over below $98 which would suggest the bear case is winning. Watch the debt-to-EBITDA ratio closely over the next two quarters, since $2.21B in leverage limits the company’s ability to invest in innovation or M&A if consumer staples competition heats up. Pay attention to gross margin trends in the next earnings report, as input cost inflation or retailer consolidation pressure could squeeze profitability faster than the 5-8% EPS growth implies. The February 13 ex-dividend date and March 2 payment will attract income investors, but if the stock breaks below $95, dividend yield alone won’t support the valuation.
Analyst Consensus
BUY

Based on 19 analyst opinions
Low Target
$74.00
Mean Target
$101.47
High Target
$115.00


Earnings and Financial Data

Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
N/A


Earnings & Dividends
Next Earnings
Jan 30, 2026
EPS (Trailing)
$3.02
Dividend Yield
122.0%
Payout Ratio
39.1%

Frequently Asked Questions

Is CHD a good stock to buy?
Yes, CHD has a “BUY” recommendation from analysts with a target price of $101.47. Given its current price of $101.35, there’s minimal upside, but the stock’s stability in the consumer defensive sector is appealing.
What is CHD’s price target?
Analysts have set a price target of $101.47 for CHD. This indicates a slight upside potential from the current price, suggesting the stock is fairly valued at this level.
Does CHD pay a dividend?
Yes, CHD offers a 122.0% dividend yield. This high yield makes it attractive for income-focused investors looking for stable returns from a defensive sector.
What is CHD’s P/E ratio?
CHD’s current P/E ratio is 33.56, with a forward P/E of 25.16. This suggests that the stock is relatively expensive compared to its earnings, but it reflects solid growth expectations in the industry.
What has been CHD’s 52-week price range?
CHD’s stock price has fluctuated between $81.33 and $116.46 over the past year. This range indicates volatility, but investors should consider the stock’s overall direction and potential for recovery from recent lows.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.